Palabras clave
Cavidad oral
Diagnóstico oral
Osteonecrosis
Osteonecrosis asociada a bisfosfonatos
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Describir la relación entre los bisfosfonatos y la osteonecrosis en Odontología. Reseña bibliográfica: La osteonecrosis inducida por el uso continuado de bisfosfonatos es una enfermedad patológica cuya principal característica es la aparición de una zona con exposición ósea en la cavidad bucal. La Asociación Estadounidense de Cirujanos Orales y Maxilofaciales aconseja a los profesionales de la salud involucrados en el tratamiento de la osteonecrosis mandibular en las etapas iniciales (I) que la terapia debe consistir en el uso de enjuagues bucales antisépticos y antibióticos para controlar la infección. En estadios avanzados (II y III) se recomienda un tratamiento más invasivo. El diagnóstico precoz de la osteonecrosis mandibular con un plan de tratamiento adecuado al caso en cuestión puede ser más beneficioso para el paciente frente a un diagnóstico de la enfermedad en estadios avanzados. Sin embargo, cada circunstancia debe ser tratada individualmente. Consideraciones finales: El diagnóstico en etapas tempranas de la osteonecrosis, junto con un plan de tratamiento adecuado, será beneficioso para el paciente, debido a que el tratamiento persiste de forma más conservadora.
Referencias
BETH T, et al. Interventions for managing medication-related osteonecrosis of the jaw (Review) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON. Cochrane Library, 2017; CD012432: 10(1–56).
DURÁN JÁC, et al. The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ). Journal of Clinical and Experimental Dentistry, 2017; 9(8): e1051–e1059.
CEPONIS P, et al. Hyperbaric oxygen therapy and osteonecrosis. Oral Diseases, 2017; 23(2): 141–151.
DUNPHY L, et al. Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. BMJ Case Reports, 2020; 13: 1.
EGUIA A, et al. Review and update on drugs related to the development of osteonecrosis of the jaw. 2020; 25: 1.
ENDO Y, et al. Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Biological and Pharmaceutical Bulletin, 2017; 40(6): 739–750.
GOODDAY RH. Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw. Oral and Maxillofacial Surgery Clinics of North America, 2015; 27(4): 527–536.
GUPTA A, et al. Rehabilitation of Edentulism and Mortality: A Systematic Review. Journal of Prosthodontics, 2019; 28(5): 526–535.
HADZIC S, et al. Importance of Early Detection of Potentially Malignant Lesions in the Prevention of Oral Cancer. Materia Socio Medica, 2017; 29(2): 129.
HENIEN M, et al. Spontaneous osteonecrosis of the maxilla. Dental Update, 2016; 43(6): 563–566.
KHALFI L, et al. Osteonecrosis Mandibular Extended to Bisphosphonates: A Very Rare Extensive Case. Cureus, 2020; 12(3).
KHAN AA, et al. J BMR Diagnosis and Management of Osteonecrosis of the Jaw : A Systematic Review and International Consensus, 2015; 30(1): 3–23.
KUROSHIMA S, et al. Medication-related osteonecrosis of the jaw: A literature review. Journal of Oral Biosciences, 2019; 61(2): 99–104.
KUŹNIK A, et al. Bisphosphonates—much more than only drugs for bone diseases. European Journal of Pharmacology, 2020; 866.
MENDES V, et al. Impact of bisphosphonate therapy on dental implant outcomes : An overview of systematic review evidence. International Journal of Oral & Maxillofacial Surgery, 2018.
MIGLIORATI CA, et al. Medication-Related Osteonecrosis of the Jaws. Journal of the National Cancer Institute - Monographs, 2019; 53: 107–115.
MÜCKE T, et al. Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review. 2016; 1: 212.
OBINATA K, et al. Image findings of bisphosphonate related Osteonecrosis of the Jaws comparing with osteoradionecrosis. Dentomaxilofac Radiol., 2017; 46(5): 20160281.
OMAMI G, Medication-Related Osteonecrosis of the Mandible. Ear, Nose and Throat Journal, 2020; 2–3.
ROSELLA D, et al. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. Journal of International Society of Preventive and Community Dentistry, 2016; 6(2): 97–104.
ROSINI S, et al. Understanding bisphosphanates and osteonecrosis of the jaws: uses and riskd. 2015; 3309–3317.
RUGGIERO SL, Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw. Oral and Maxillofacial Surgery Clinics of North America, 2015; 27(4): 479–487.
SALEHI B, et al. Plant-derived bioactives in oral mucosal lesions: A key emphasis to Curcumin, Lycopene, chamomile, aloe Vera, green tea and coffee properties. Biomolecules, 2019; 9(3).
SANTOS M, et al. Extensive osteonecrosis of the maxilla caused by bisphosphonates: Report of a rare case. Journal of Clinical and Experimental Dentistry, 2019; 11(2): e203–e207.
SHIM Y, et al. Analysis of Factors Associated with the Postoperative Healing of Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. 2021.
SILVA LF, et al. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. 2015.
SMITH JD, et al. Maxilla Osteonecrosis: A Differential Diagnosis in Patients with Metastatic Cancer on Bisphosphonates. Journal of Case Reports in Medicine, 2016; 5: 1–3.
SPANOU A, et al. Management of bisphosphonate-related osteonecrosis of the jaw: A literature review. Oral Diseases, 2015; 21(8): 927–936.
STEINER C, Schleimhauterkrankungen: Differenzial diagnostischer zugang aus kieferchirurgischer sicht. Hautarzt, 2016; 67(10): 816–821.
VILLA A, et al. Leukoplakia—A Diagnostic and Management Algorithm. Journal of Oral and Maxillofacial Surgery, 2017; 75(4): 723–734.
WALKER AW. Microbiota of the Human Body, 2016; 902: 5–32.
WARNAKULASURIYA S. White, red, and mixed lesions of oral mucosa: A clinicopathologic approach to diagnosis. Periodontology, 2000; 80(1): 89–104.
WASSERZUG O, et al. Involvement of the maxillary sinus in bisphosphonaterelated osteonecrosis of the jaw: Radiologic aspects. American Journal of Rhinology and Allergy, 2017; 31(1): 36–39.
ZHANG L, et al. The Oral Microbiota May Have Influence on Oral Cancer. Frontiers in Cellular and Infection Microbiology, 2020; 9.